Avalo Therapeutics (AVTX) Cash from Operations (2014 - 2026)
Avalo Therapeutics posted quarterly Cash from Operations of 17700000.0 for Q1 2026, down 87.16% year-on-year from 137882125.21 in Q1 2025, and down 23.88% on a QoQ basis from 14288000.0 in Q4 2025.
Avalo Therapeutics (AVTX) has 13 years of Cash from Operations data on file, last reported at 17700000.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Operations fell 87.16% year-over-year to 17700000.0; the trailing twelve-month figure through Mar 2026 stood at 59743000.0 (down 14.21% YoY), and the FY2025 full-year result was 51500000.0, down 4.98% from the prior year.
- Cash from Operations for Q1 2026 stood at 17700000.0, down from 14288000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 5726000.0 in Q3 2022 and bottomed at 17700000.0 in Q1 2026.
- The 5-year median for Cash from Operations is 11390000.0 (2025), against an average of 10334529.41.
- The widest annual swing landed in 2022, when Cash from Operations soared 135.15%; it then sank 443.89% in 2024.
- A 5-year view of Cash from Operations shows it stood at 3940000.0 in 2022, then climbed by 29.8% to 2766000.0 in 2023, then tumbled by 443.89% to 15044000.0 in 2024, then grew by 5.03% to 14288000.0 in 2025, then retreated by 23.88% to 17700000.0 in 2026.
- The last three Cash from Operations figures came in at 17700000.0 (Q1 2026), 14288000.0 (Q4 2025), and 16365000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -1.67 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -12.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.49 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.43 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.08 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 70.50 Mn |
| 10 | Avalo Therapeutics | 317.29 Mn | 317.29 Mn | - | -17.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -17.70 Mn |
| Mar 31, 2026 | -17.70 Mn |
| Dec 31, 2025 | -14.29 Mn |
| Dec 31, 2025 | -14.29 Mn |
| Sep 30, 2025 | -16.37 Mn |
| Sep 30, 2025 | -16.37 Mn |
| Jun 30, 2025 | -11.39 Mn |
| Jun 30, 2025 | -11.39 Mn |
| Mar 31, 2025 | -9.46 Mn |
| Mar 31, 2025 | -9.46 Mn |
| Dec 31, 2024 | -15.04 Mn |
| Dec 31, 2024 | -15.04 Mn |
| Sep 30, 2024 | -11.53 Mn |
| Sep 30, 2024 | -11.53 Mn |
| Jun 30, 2024 | -16.28 Mn |
| Jun 30, 2024 | -16.28 Mn |
| Mar 31, 2024 | -6.20 Mn |
| Mar 31, 2024 | -6.20 Mn |
| Dec 31, 2023 | -2.77 Mn |
| Dec 31, 2023 | -2.77 Mn |
| Sep 30, 2023 | -6.84 Mn |
| Sep 30, 2023 | -6.84 Mn |
| Jun 30, 2023 | -11.03 Mn |
| Jun 30, 2023 | -11.03 Mn |
| Mar 31, 2023 | -10.05 Mn |
| Mar 31, 2023 | -10.05 Mn |
| Dec 31, 2022 | -3.94 Mn |
| Dec 31, 2022 | -3.94 Mn |
| Sep 30, 2022 | 5.73 Mn |
| Sep 30, 2022 | 5.73 Mn |
| Jun 30, 2022 | -12.47 Mn |
| Jun 30, 2022 | -12.47 Mn |
| Mar 31, 2022 | -16.07 Mn |
| Mar 31, 2022 | -16.07 Mn |
| Dec 31, 2021 | -17.10 Mn |
| Dec 31, 2021 | -17.10 Mn |
| Sep 30, 2021 | -16.29 Mn |
| Sep 30, 2021 | -16.29 Mn |
| Jun 30, 2021 | -19.19 Mn |
| Jun 30, 2021 | -19.19 Mn |
| Mar 31, 2021 | -18.32 Mn |
| Mar 31, 2021 | -18.32 Mn |
| Dec 31, 2020 | -14.38 Mn |
| Dec 31, 2020 | -14.38 Mn |
| Sep 30, 2020 | -11.87 Mn |
| Sep 30, 2020 | -11.87 Mn |
| Jun 30, 2020 | -8.56 Mn |
| Jun 30, 2020 | -8.56 Mn |
| Mar 31, 2020 | -5.74 Mn |
| Mar 31, 2020 | -5.74 Mn |
| Dec 31, 2019 | -1.68 Mn |
| Dec 31, 2019 | -1.68 Mn |
| Sep 30, 2019 | -7.62 Mn |
| Sep 30, 2019 | -7.62 Mn |
| Jun 30, 2019 | -6.72 Mn |
| Jun 30, 2019 | -6.72 Mn |
| Mar 31, 2019 | -3.12 Mn |
| Mar 31, 2019 | -3.12 Mn |
| Dec 31, 2018 | -1.98 Mn |
| Dec 31, 2018 | -1.98 Mn |
| Sep 30, 2018 | -538,350.00 |
| Sep 30, 2018 | -538,350.00 |
| Jun 30, 2018 | -333,673.00 |
| Jun 30, 2018 | -333,673.00 |
| Mar 31, 2018 | -280,423.00 |
| Mar 31, 2018 | -280,423.00 |
| Dec 31, 2017 | -2.55 Mn |
| Dec 31, 2017 | -2.55 Mn |
| Sep 30, 2017 | 19.12 Mn |
| Sep 30, 2017 | 19.12 Mn |
| Jun 30, 2017 | -1.76 Mn |
| Jun 30, 2017 | -1.76 Mn |
| Mar 31, 2017 | -2.24 Mn |
| Mar 31, 2017 | -2.24 Mn |
| Dec 31, 2016 | -3.71 Mn |
| Dec 31, 2016 | -3.71 Mn |
| Sep 30, 2016 | -3.43 Mn |
| Sep 30, 2016 | -3.43 Mn |
| Jun 30, 2016 | -3.72 Mn |
| Jun 30, 2016 | -3.72 Mn |
| Mar 31, 2016 | -3.71 Mn |
| Mar 31, 2016 | -3.71 Mn |
| Dec 31, 2015 | -3.55 Mn |
| Dec 31, 2015 | -3.55 Mn |
| Sep 30, 2015 | -1.81 Mn |
| Sep 30, 2015 | -1.81 Mn |
| Jun 30, 2015 | -1.73 Mn |
| Jun 30, 2015 | -1.73 Mn |
| Mar 31, 2015 | -3.07 Mn |
| Mar 31, 2015 | -3.07 Mn |
| Dec 31, 2014 | -3.97 Mn |
| Dec 31, 2014 | -3.97 Mn |